| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212403 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 31 Pages |
Abstract
Our patient outcomes closely matched those of the CALGB trial, suggesting that its results are generalizable to a population of elderly breast cancer patients with typical HT adherence. The CALGB trial results, as well as the resulting practice guideline, did not change the use of adjuvant HT-RT in our population-based cancer program.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alan M. MD, Elisa K. MD, Sarah MD, Sally L. MD, Lovedeep PDC, Caroline BA, Scott MD, MSc,